Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Adult ADHD: Questioning Diagnosis and Treatment in a Patient with Multiple Psychiatric Comorbidities.

Chu RK, Rosic T, Samaan Z.

Case Rep Psychiatry. 2017;2017:1364894. doi: 10.1155/2017/1364894. Epub 2017 Jun 11.

2.

Analytical characterization and pharmacological evaluation of the new psychoactive substance 4-fluoromethylphenidate (4F-MPH) and differentiation between the (±)-threo and (±)-erythro diastereomers.

McLaughlin G, Morris N, Kavanagh PV, Power JD, Dowling G, Twamley B, O'Brien J, Hessman G, Murphy B, Walther D, Partilla JS, Baumann MH, Brandt SD.

Drug Test Anal. 2017 Mar;9(3):347-357. doi: 10.1002/dta.2167. Epub 2017 Mar 7.

3.

Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology.

Smith CT, Weafer J, Cowan RL, Kessler RM, Palmer AA, de Wit H, Zald DH.

J Psychopharmacol. 2016 Apr;30(4):330-43. doi: 10.1177/0269881116631650. Epub 2016 Feb 15.

4.

Clinical potential of methylphenidate in the treatment of cocaine addiction: a review of the current evidence.

Dürsteler KM, Berger EM, Strasser J, Caflisch C, Mutschler J, Herdener M, Vogel M.

Subst Abuse Rehabil. 2015 Jun 17;6:61-74. doi: 10.2147/SAR.S50807. eCollection 2015. Review.

5.

Prevalent intravenous abuse of methylphenidate among treatment-seeking patients with substance abuse disorders: a descriptive population-based study.

Bjarnadottir GD, Haraldsson HM, Rafnar BO, Sigurdsson E, Steingrimsson S, Johannsson M, Bragadottir H, Magnusson A.

J Addict Med. 2015 May-Jun;9(3):188-94. doi: 10.1097/ADM.0000000000000115.

6.
7.

Prior methylphenidate self-administration alters the subsequent reinforcing effects of methamphetamine in rats.

Baladi MG, Nielsen SM, Umpierre A, Hanson GR, Fleckenstein AE.

Behav Pharmacol. 2014 Dec;25(8):758-65. doi: 10.1097/FBP.0000000000000094.

8.

Influence of sensitization on the discriminative stimulus effects of methylphenidate in mice.

McGovern R, Luderman L, Knecht K, Griffin WC 3rd.

Behav Pharmacol. 2014 Dec;25(8):766-74. doi: 10.1097/FBP.0000000000000095.

9.

Behavioral and neuronal recording of the nucleus accumbens in adolescent rats following acute and repetitive exposure to methylphenidate.

Frolov A, Reyes-Vasquez C, Dafny N.

J Neurophysiol. 2015 Jan 1;113(1):369-79. doi: 10.1152/jn.00633.2013. Epub 2014 Oct 15.

10.

Modafinil alters intrinsic functional connectivity of the right posterior insula: a pharmacological resting state fMRI study.

Cera N, Tartaro A, Sensi SL.

PLoS One. 2014 Sep 19;9(9):e107145. doi: 10.1371/journal.pone.0107145. eCollection 2014.

11.

An assessment of an automated EEG biofeedback system for attention deficits in a substance use disorders residential treatment setting.

Keith JR, Rapgay L, Theodore D, Schwartz JM, Ross JL.

Psychol Addict Behav. 2015 Mar;29(1):17-25. doi: 10.1037/adb0000016. Epub 2014 Sep 1.

12.

Stimulant ADHD medication and risk for substance abuse.

Chang Z, Lichtenstein P, Halldner L, D'Onofrio B, Serlachius E, Fazel S, Långström N, Larsson H.

J Child Psychol Psychiatry. 2014 Aug;55(8):878-85. doi: 10.1111/jcpp.12164. Epub 2013 Oct 25.

13.

Targeting impulsivity in Parkinson's disease using atomoxetine.

Kehagia AA, Housden CR, Regenthal R, Barker RA, Müller U, Rowe J, Sahakian BJ, Robbins TW.

Brain. 2014 Jul;137(Pt 7):1986-97. doi: 10.1093/brain/awu117. Epub 2014 Jun 3.

14.

The behavioral economics of substance use disorders: reinforcement pathologies and their repair.

Bickel WK, Johnson MW, Koffarnus MN, MacKillop J, Murphy JG.

Annu Rev Clin Psychol. 2014;10:641-77. doi: 10.1146/annurev-clinpsy-032813-153724. Review.

15.

Life context of pharmacological academic performance enhancement among university students--a qualitative approach.

Hildt E, Lieb K, Franke AG.

BMC Med Ethics. 2014 Mar 7;15:23. doi: 10.1186/1472-6939-15-23.

16.

The implications of methylphenidate use by healthy medical students and doctors in South Africa.

Beyer C, Staunton C, Moodley K.

BMC Med Ethics. 2014 Mar 4;15:20. doi: 10.1186/1472-6939-15-20. Review.

17.

Acute effects of modafinil on brain resting state networks in young healthy subjects.

Esposito R, Cilli F, Pieramico V, Ferretti A, Macchia A, Tommasi M, Saggino A, Ciavardelli D, Manna A, Navarra R, Cieri F, Stuppia L, Tartaro A, Sensi SL.

PLoS One. 2013 Jul 25;8(7):e69224. doi: 10.1371/journal.pone.0069224. Print 2013.

18.

Capillary electrophoresis-mass spectrometry-based detection of drugs and neurotransmitters in Drosophila brain.

Phan NT, Hanrieder J, Berglund EC, Ewing AG.

Anal Chem. 2013 Sep 3;85(17):8448-54. doi: 10.1021/ac401920v. Epub 2013 Aug 19.

19.

Effects of chronic methylphenidate in adolescence on later methylphenidate self-administration in rhesus monkeys.

Martelle SE, Porrino LJ, Nader MA.

Behav Pharmacol. 2013 Sep;24(5-6):478-81. doi: 10.1097/FBP.0b013e328364bfee.

20.

Adult female rats' altered diurnal locomotor activity pattern following chronic methylphenidate treatment.

Trinh TN, Kohllepel SR, Yang PB, Burau KD, Dafny N.

J Neural Transm (Vienna). 2013 Dec;120(12):1717-31. doi: 10.1007/s00702-013-1063-4. Epub 2013 Jul 27.

Supplemental Content

Support Center